- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06109753
Ergonomic Benefits From Robotically Assisted Laparoscopy for Hysterectomies and Other Indications (ERCON)
Ergonomic Benefits From Robotically Assisted Laparoscopy for Hysterectomies and Other Selected Indications in Comparison to Conventional Laparoscopy - an Explorative Study
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Bernhard Krämer, Prof. Dr.
- Phone Number: : +49 7071 29 82211
- Email: bernhard.kraemer@med.uni-tuebingen.de
Study Locations
-
-
Baden-Württemberg
-
Tübingen, Baden-Württemberg, Germany, 72076
- Recruiting
- University Women's Hospital
-
Contact:
- Bernhard Krämer, Prof. Dr.
- Email: bernhard.kraemer@med.uni-tuebingen.de
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Age between 18 and 68 years
- surgeons that are able to work in full shift
- trained surgeons in RALS and CLS
- written informed consent
Exclusion Criteria:
- persons influenced by analgesics or muscle relaxants
- persons not able to perform their common work for any reason
- persons with acute diseases
- muscle injury
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Robotically Assisted Laparoscopy
Surgeons perform robot-assisted laparoscopic surgery
|
robotically assisted surgeries of about 60-minute duration with additional 30 min for preparing with the measurement equipment before surgery and 15 post evaluation of the corresponding surgery
|
Conventional Laparoscopy
Surgeons perform conventional laparoscopic surgery
|
conventional surgeries of about 60-minute duration with additional 30 min for preparing with the measurement equipment before surgery and 15 post evaluation of the corresponding surgery
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Muscle activity of the bilateral trapezius pars descendens muscle
Time Frame: during surgery
|
The muscle activity of the bilateral trapezius pars descendens muscle will be assessed using surface electromyography, with the root-mean-square (RMS) of electrical muscle activity recordings measured through bipolar surface electrodes.
Data will be normalized to an isometric voluntary maximum electrical activation (MVE).
|
during surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Muscle activity of the bilateral forearm muscles
Time Frame: during surgery
|
The muscle activity of the bilateral forearm muscles will be assessed using surface electromyography, with the root-mean-square (RMS) of electrical muscle activity recordings measured through bipolar surface electrodes.
Data will be normalized to an isometric voluntary maximum electrical activation (MVE).
|
during surgery
|
Kinematics
Time Frame: during surgery
|
For kinematics, the outcome measures involve the assessment of shoulder abduction, trunk, and head flexion angles in degrees, which are determined using gravimetric position sensors, providing precise measurements of body positioning during the task.
|
during surgery
|
Perceived physical discomfort
Time Frame: during surgery
|
Perceived physical discomfort is evaluated by assessing its frequency and intensity.
Frequency indicates the number of occurrences, while intensity is measured on a 0 to 10 scale, where higher values indicate more intense discomfort.
These measurements are recorded at 20-minute intervals to monitor changes in discomfort over time.
|
during surgery
|
Perceived mental demand
Time Frame: during surgery
|
Perceived mental demand is evaluated using the NASA (National Aeronautics and Space Administration ) Task Load Index (TLX) questionnaire's mental demand dimension, providing a subjective score ranging from 0 to 21, reflecting the perceived cognitive load during the task.
Higher values are representing higher perceived mental demand.
|
during surgery
|
Perceived mental demand - Heart rate
Time Frame: during surgery
|
Heart rate (beats per minute) and heart rate variability, such as SDNN (standard deviation of the beat-to-beat differences in instantaneous heart rate), are recorded via electrocardiography to quantify physiological responses associated with mental demand.
|
during surgery
|
Perceived mental demand - Heart rate variability
Time Frame: during surgery
|
Heart rate variability, to be precise SDNN (standard deviation of the beat-to-beat differences in instantaneous heart rate), are recorded via electrocardiography to quantify physiological responses associated with mental demand.
|
during surgery
|
Work precision
Time Frame: during surgery
|
Work precision is measured during surgery using a visual analogue scale ranging from 0 to 100 mm, providing an indication of the precision and accuracy of the surgical maneuvers performed.
|
during surgery
|
Eye strain
Time Frame: during surgery
|
Eye strain is evaluated using a 10-item questionnaire designed to assess the severity of eye strain, with each question scored on a scale from 0 to 6, aiding in the comprehensive understanding of the subjective experience of visual discomfort.
|
during surgery
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Musculoskeletal complaints
Time Frame: within the last 12 months
|
The Nordic Questionnaire encompasses an evaluation of diverse parameters, including body height (measured in centimeters), body weight (measured in kilograms), physical activity (assessed in hours of sports per week), work experience (measured in years), and the presence of musculoskeletal complaints within the last 12 months, along with point prevalence [n]. This holistic assessment offers critical insights into the participants' physical condition and occupational health status. Additionally, please note that the Nordic Questionnaire does not specifically employ a single scale; rather, it utilizes various metrics tailored to the different parameters, and thus, the measurement scales can differ based on the specific parameter being assessed. |
within the last 12 months
|
Duration of the surgical procedure
Time Frame: 105 Minutes
|
The duration of the surgical procedure is a critical outcome measure, recorded in minutes, providing a precise indication of the time taken to complete the specific surgical intervention, aiding in the assessment of surgical efficiency and time management.
|
105 Minutes
|
Difficulty of the surgery
Time Frame: 5 Minutes
|
The perceived difficulty of the surgery is measured using a visual analogue scale ranging from 0 to 100 mm, with 0 indicating that the surgery was not difficult and 100 indicating that the surgery was very difficult.
This measure allows the surgeons to subjectively express the complexity and challenges associated with the performed surgical procedure.
|
5 Minutes
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Benjamin Steinhilber, PD Dr., Institute of Occupational and Social Medicine and Health Services Research
- Principal Investigator: Bernhard Krämer, Prof. Dr., University Women's Hospital
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- MT_ASENSUS SOS
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Musculoskeletal Diseases or Conditions
-
Chinese University of Hong KongCompletedMusculoskeletal Diseases or ConditionsHong Kong
-
Revmatismesykehuset ASSouth-Eastern Norway Regional Health AuthorityCompletedMusculoskeletal Diseases or ConditionsNorway
-
Sunnybrook Health Sciences CentreNot yet recruitingMusculoskeletal Diseases or Conditions
-
Chinese University of Hong KongRecruitingMusculoskeletal Diseases or ConditionsHong Kong
-
Chinese University of Hong KongRecruitingMusculoskeletal Diseases or ConditionsHong Kong
-
University of ValladolidSanidad de Castilla y LeónCompletedMusculoskeletal Diseases or ConditionsSpain
-
Chinese University of Hong KongCompletedMusculoskeletal Diseases or ConditionsHong Kong
-
Chinese University of Hong KongCompletedMusculoskeletal Diseases or ConditionsHong Kong
-
University of ArkansasNational Institutes of Health (NIH)WithdrawnMusculoskeletal Diseases or ConditionsUnited States
-
Chinese University of Hong KongWithdrawnMusculoskeletal Diseases or ConditionsHong Kong
Clinical Trials on Robotically Assisted Laparoscopic Surgery
-
Wiktor Dega University Orthopedic and Rehabilitation...Recruiting
-
Hospital Universitari Vall d'Hebron Research InstituteCompletedSurgery--Complications
-
Changhai HospitalUnknownNephrectomy | Robotic Surgical Procedures | ProstatectomyChina
-
Fondazione Policlinico Universitario Agostino Gemelli...Not yet recruitingGynecologic Cancer | Endometrial Neoplasms | Obesity, Morbid | Endometrial Cancer | Gynecologic Disease
-
Kyungpook National University HospitalUnknownRectal CancerKorea, Republic of
-
Southwest Hospital, ChinaRecruiting
-
University of GenovaUniversity of Vienna; University of AmsterdamCompletedPostoperative Respiratory Complication
-
City of Hope Medical CenterWithdrawnRecurrent Rectal Cancer | Stage I Rectal Cancer | Stage II Rectal Cancer | Stage III Rectal Cancer
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedRecurrent Renal Cell Cancer | Stage I Renal Cell Cancer | Stage II Renal Cell CancerUnited States
-
M.D. Anderson Cancer CenterCompletedBladder CancerUnited States